The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Alere Inc

NYSE: ALR
Last

(U.S.) $48.90

Today's change0.00 0.00%
Updated March 31 4:02 PM EDT. Delayed by at least 15 minutes.
 

Alere Inc

NYSE: ALR
Last

(U.S.) $48.90

Today's change0.00 0.00%
Updated March 31 4:02 PM EDT. Delayed by at least 15 minutes.

Alere Inc closed at (U.S.)$48.90.

Over the last five days, shares have gained 2.30% and are currently 1.15% off of the 52-week high. Shares have outperformed the S&P 500 by 31.91% during the last year.

Key company metrics

  • Open(U.S.) $48.36
  • Previous close(U.S.) $48.90
  • High(U.S.) $49.16
  • Low(U.S.) $48.22
  • Bid / Ask-- / --
  • YTD % change+28.68%
  • Volume379,970
  • Average volume (10-day)446,294
  • Average volume (1-month)662,846
  • Average volume (3-month)643,432
  • 52-week range(U.S.) $31.94 to (U.S.) $49.47
  • Beta1.93
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward20.16×
  • Forward PEG2.02×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.27
Updated March 31 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-7.16%

Alere Inc has a net profit margin of -7.16%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue397736738717
Total other revenue--------
Total revenue397736738717
Gross profit191349340351
Total cost of revenue206388398365
Total operating expense366699747691
Selling / general / administrative107260298280
Research & development29333439
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2518176
Other operating expenses, total--------
Operating income3137-926
Interest income (expense), net non-operating-53-52-52-52
Gain (loss) on sale of assets--------
Other--------
Income before tax-24-23-58-21
Income after tax-27-100-52-11
Income tax, total477-7-10
Net income152-86-50-6
Total adjustments to net income-5-5-5-5
Net income before extra. items-24-93-50-6
Minority interest0000
Equity in affiliates4625
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-29-99-55-11
Inc. avail. to common incl. extra. items147-92-55-11
Diluted net income147-92-55-11
Dilution adjustment0000
Diluted weighted average shares84838382
Diluted EPS excluding extraordinary itemsvalue per share-0.35-1.19-0.67-0.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.16-1.05-0.53-0.05